PTEN and immunodeficiency disease: Similarly, the genotypability of RPSA (associated with the immunodeficiency disease Isolated congenital asplenia – OMIM 271400 –) improved from 63.29% to 100%, and that of the tumor suppressor gene PTEN improved from 78.55% to 100% (Table 9 and Supplementary Table S3).